According to GuruFocus list of 5-year lows, these Guru stocks have reached their 5-year lows: Science Applications International Corp, Grana y Montero SAA, Piedmont Office Realty Trust Inc, and OiSA
Science Applications International Corp (SAIC) Reached the Five-Year Low of $32.20
The prices of Science Applications International Corp (SAIC) shares have declined to close to the five-year low of $32.20, which is 26.3% off the five-year high of $39.88. Science Applications International Corp is owned by one Guru we are tracking. Among them, 1 have added to their positions during the past quarter. Zero reduced their positions. Science Applications International Corp has a market cap of $2.76 billion; its shares were traded at around $32.20 with a P/E ratio of 18.50 and P/S ratio of 0.45. The dividend yield of Science Applications International Corp stocks is 0.87%.
Science Applications International Corp announced their 2014 third quarter fiscal results with revenues of $974 million and net income of $22 million.
Top 5 Paper Stocks To Own For 2015: KB Home (KBH)
KB Home is a homebuilding company. The Company constructs and sells homes through its operating divisions under the name KB Home. The Company operates in nine states and 32 markets, including California, Arizona, Nevada, Colorado, Texas, Florida, Maryland, North Carolina and Virginia. The Company organizes its homebuilding operations into four segments: West Coast, Southwest, Central and Southeast. In July 2012, it acquired land within the Elworthy Ranch property in the town of Danville. In September 2012, it acquired Mason Ranch, which is a 330-acre land asset in Cedar Park/Leander West, submarkets in metropolitan Austin. In December 2012, the Company acquired 65 lots in Fuquay-Varina, N.C.
Homebuilding
The Company�� homebuilding operations offers a variety of homes designed primarily for first-time, move-up and active adult homebuyers, including attached and detached single-family homes, townhomes and condominiums. It offers homes in development communities, at urban in-fill locations and as part of mixed-use projects. During the fiscal year ended, November 30, 2011 (fiscal 2011), the Company, through its homebuilding segment, delivered 5,812 homes. During fiscal 2011, homebuilding operations accounted for 99.2% of the total revenues.
Financial Services
The financial services segment provides title and insurance services to its homebuyers. This segment also provided mortgage banking services to the Company�� homebuyers indirectly through KBA Mortgage, LLC (KBA Mortgage), a former unconsolidated joint venture of a subsidiary of ours and a subsidiary of Bank of America, N.A., from the venture�� formation until June 30, 2011, when it ceased offering mortgage banking services. Effective June 27, 2011, it entered into a marketing services agreement with MetLife Home Loans, a division of MetLife Bank, N.A. Under the agreement, MetLife Home Loans��personnel, located on site at several of its new home communities, can offer financing options and re! sidential consumer mortgage loan products to its homebuyers, and originate residential consumer mortgage loans for homebuyers who elect to use MetLife Home Loans. The Company�� homebuyers may also elect to use other providers of mortgage banking services. Its financial services operations accounted for 0.8% of the Company�� total revenues in fiscal 2011.
Advisors' Opinion:- [By Anora Mahmudova]
Shares in KB Home (KBH) �jumped 5.9% after the home maker swung to profit in its fiscal first quarter, beating analysts estimates.
- [By Holly LaFon]
Pimco managing director Mark Kiesel mentions Whirlpool (WHR), Weyerhaeuser (WY), USG (USG), Toll Brothers (TOLL) and KB Home (KBH) as good plays on housing:�
- [By Jacob Roche]
Sherwin-Williams, along with some other home-improvement stocks, benefits from being part of that rare breed of stocks that do well when times are good, and still do well when times are bad. If the housing market is good, new homes get built en masse, and those homes need to be painted and floored. Hence, with U.S. housing starts up nearly 90% over the past couple of years, homebuilders KB Homes (NYSE: KBH ) and Beazer Homes (NYSE: BZH ) have seen revenues finally starting to recover, and companies such as Sherwin-Williams and Lumber Liquidators (NYSE: LL ) are being pulled along for the ride.
Hot International Companies To Buy For 2014: Bulova Technologies Group Inc (BTGI)
Bulova Technologies Group, Inc. (BLVT), incorporated in 1979, operates as a Government contractor in the United States. BLVT�� operating facilities are located in Mayo, Florida. As of September 30, 2011, the Company is focused on Department of Defense contracting. As of September 30, 2011, BLVT operated corporate and administrative offices in two leased facilities, one in Clearwater, Florida, approximating 2,400 square feet, and the other in Brandon, Florida, approximating 5,000 square feet. The Company�� Government contracting business is located on 261 acres owned by the Company in Mayo, Florida, where it operates a load, assembly, and pack facility specializing in fuzes, safe and arming devices and explosive simulators. There are more than 38 buildings on the property consisting of warehouses, storage, and manufacturing facilities. In March 31, 2011, the Company disposed of its subsidiary BT Manufacturing Company LLC. In October 2012, the Company sold Bulova Technologies Ordnance Systems LLC.
Bulova Technologies Ordnance Systems LLC is a load, assembly, and pack facility specializing in fuzes, safe and arming devices and explosive simulators. Bulova Technologies Ordnance Systems LLC produces a range of pyrotechnic devices, ammunition and other energetic materials for the United States Government and other allied Governments worldwide. Bulova Technologies (Europe) LLC is developing a mortar exchange program to facilitate the needs of NATO member countries.
Advisors' Opinion:- [By Peter Graham]
A quick look at Hybrid Coating Technologies��financials reveals revenues of $48k (most recent reported quarter), $5k, $3k and $53k for the past four reported quarters along with net losses of $821k (most recent reported quarter), $1,571k, $774k and $510. At the end of September, Hybrid Coating Technologies had no cash to cover $4,037k in current liabilities and $1,279k in long term debt. So while the global industrial and specialty coatings market might be worth $35 billion, Hybrid Coating Technologies has yet to grab enough of it.
Bulova Technologies Group, Inc (OTCMKTS: BTGI) Recently Did a Reverse SplitSmall cap Bulova Technologies Group has an extensive history of large scale Defense Contracts for munitions, weapons systems and combat systems. On Friday, Bulova Technologies Group fell 13.04% to $0.0300 for a market cap of $663,789 plus BTGI is up 29,900% over the past year and down 66.7% over the past five years according to Google Finance.
Hot International Companies To Buy For 2014: Genomic Health Inc (GHDX)
Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.
Oncotype DX Platform
The Company�� Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient'! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.
Oncotype DX Breast Cancer Test
To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.
In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.
Oncotype DX Colon Cancer Test
The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and recurrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.
The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.
Advisors' Opinion:- [By John Udovich]
Large and small cap cancer stocks Gilead Sciences, Inc (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Veracyte (NASDAQ: VCYT), Genomic Health, Inc (NASDAQ: GHDX), Cell Therapeutics Inc (NASDAQ: CTIC) and MetaStat Inc (OTCMKTS: MTST) have all been producing a steady stream of news lately for biotech investors looking for a way to cash in on the growth in development of�cancer treatments. Just consider the following news:
- [By John Udovich]
On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had�Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50%���a nice return in just two weeks time.
Hot International Companies To Buy For 2014: Boise Cascade Co (BCC)
Boise Cascade Company, formerly Boise Cascade, L.L.C., incorporated on July 26, 2004, is a vertically-integrated wood products manufacturer and building materials distributor with operations throughout the United States and Canada. The Company operates in two segments: wood products segment and our building materials distribution segment. The Company manufactures engineered wood products, plywood, lumber, and particleboard and distributes a line of building materials, including wood products manufactured by the Company�� wood products division. The Company�� products are used primarily in new residential construction, residential repair and remodeling projects, light commercial construction and industrial applications. In September 2013, the Company announced that it has completed the acquisition of Wood Resources LLC's Southeast Operations, which include Chester Wood Products LLC and Moncure Plywood LLC.
Wood Products
The Company�� wood products segment is a manufacturer of engineered wood products (EWP) and plywood in North America. It manufactures LVL, I-joists and laminated beams and also produces plywood, studs, particleboard and ponderosa pine lumber, a lumber grade sold primarily to manufacturers of specialty wood windows, moldings and doors. Most of its wood products are sold to wholesalers, including its building materials distribution segment, home improvement centers, retail lumberyards and industrial converters.
Building Materials Distribution
The Company is a wholesale distributor of building materials in the United States. Its nationwide network of 31 strategically-located distribution facilities sells a line of building materials, including EWP, oriented strand board OSB), plywood, lumber and general line items, such as framing accessories, composite decking, roofing, siding and insulation. It also operates a truss manufacturing plant located in Maine. Its products are used in the construction of new residential housing,! including single-family, multi-family and manufactured homes, repair and remodeling projects and the construction of light industrial and commercial buildings.
The Company markets its products primarily to retail lumberyards and home improvement centers that then sell the products to end customers, who are typically professional builders, independent contractors and homeowners engaged in residential construction projects. It also markets its products to industrial converters, which use its products to assemble windows, doors, agricultural bins and other products used in industrial and repair and remodel applications. The Company has more than 4,500 customers, which includes a diverse mix of wholesalers, home improvement centers, retail lumberyards and industrial converters. The Company supplies its customers through 49 located facilities (consisting of 18 manufacturing facilities and 31 distribution facilities).
Advisors' Opinion:- [By Eric Volkman]
A sizable block of Boise Cascade (NYSE: BCC ) stock is to land in new hands if a secondary common stock offering goes as planned. The company announced that major shareholder Boise Cascade Holdings will sell 10 million shares in an underwritten issue, at a price of $27.00 apiece. Additionally, the offering's underwriters have been granted a 30-day purchase option for up to an additional 1.5-million shares at the same price, minus underwriting discounts.
- [By Jon C. Ogg]
Boise Cascade LLC (NYSE: BCC) was raised to Buy from Neutral at D.A. Davidson.
Embraer�S.A. (NYSE: ERJ) was initiated as Outperform at RBC Capital Markets.
- [By Blake Bos]
Investors searching for a lucrative investment to capitalize on a continued rebound in housing may have found the process to be quite precarious, as many companies have experienced significant run-ups in stock price. While most company valuations appear frothy,�Boise Cascade (NYSE: BCC ) �stands out as a possible cheaper alternative. In the video below, analyst Blake Bos shows you how to ask the right questions when deciding to invest and draws some valuable comparisons to competitor�Weyerhaeuser� (NYSE: WY ) .�
- [By Ben Levisohn]
Shares of Rayonier have plunged 15% to $46.97 at 12.36 p.m., but its fall doesn’t seem to have damaged other timber companies. Weyerhaeuser (WY) has gained 3.7% to $31.43 after it reported a profit of 27 cents today, beating estimates of 21 cents. Plum Creek Timber (PCL) is little changed at $49.47 and Boise Cascade (BCC) has risen 1.1% to $27.83.
Hot International Companies To Buy For 2014: Powershares Etf Fund Trusts Ii (PGX)
The PowerShares Preferred Portfolio (Fund) is based on The BofA Merrill Lynch Core Fixed Rate Preferred Securities Index (Index). The Fund normally invest at least 90% of its total assets in securities that comprise the Index. The Index is designed to replicate the total return of a diversified group of investment-grade preferred securities. The Index is rebalanced on a monthly basis. The Fund seeks investment results that correspond generally to the price and yield (before fees and expenses) of a securities index. The Fund invests in sectors, such as basic materials, financial, utilities and unclassified. Invesco PowerShares Capital Management LLC. is the investment adviser. Advisors' Opinion:- [By Lawrence Meyers]
Public Storage has 10 different series of preferred stock, but I like the Series T because it trades at $21.83, which is more than 12% below par. I don�� see any reason for this discount, and it also boosts the 5.75% dividend (at par) to 6.58% at the current price.
Preferred Stocks to Buy: PowerShares Preferred Portfolio (PGX)
Dividend Yield: 6.6%
Hot International Companies To Buy For 2014: Build-A-Bear Workshop Inc. (BBW)
Build-A-Bear Workshop, Inc. operates as a specialty retailer of plush animals and related products. The company�s merchandise comprises various styles of animals to be stuffed; clothing, shoes, and accessories for the stuffed animals; and other brand appropriate toy and accessory items. It also licenses its Build-A-Bear Workshop brand to third parties to manufacture and sell merchandise to other retailers. As of January 31, 2013, the company operated approximately 400 Build-A-Bear Workshop stores worldwide, including the company-owned stores in the United States, Puerto Rico, Canada, the United Kingdom, and Ireland, as well as franchised stores in Europe, Asia, Australia, Africa, the Middle East, Mexico, and South America. The company also sells its products through a Web store. Build-A-Bear Workshop, Inc. was founded in 1997 and is headquartered in St. Louis, Missouri.
Advisors' Opinion:- [By Tabitha Jean Naylor]
Build-A-Bear Workshop (NYSE: BBW).��Unlike traditional toy manufacturers that make toys and games and distribute them to retailers, Build-A-Bear has flipped the toy-making concept on its ear. The idea of making a stuffed animal from scratch has taken the toy market by storm, and has carved out a nice little niche market for the company.
- [By Rich Smith]
After four months of looking, Build-A-Bear (NYSE: BBW ) has found-a-CEO.
After close of trading Monday, Build-A-Bear Workshop announced it has chosen Sharon Price John to become its new Chief Executive Officer and Chief President Bear. She will replace outgoing Chief Executive Bear�(the cute titles are undergoing a bit of a change) Maxine Clark, company founder, who announced her own intention to retire back in February.
Hot International Companies To Buy For 2014: Sigma Labs Inc (SGLB)
Sigma Labs, Inc., incorporated on December 23, 1985, has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies, as well as Reasearch and Development solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates provide consultants to Federal government and commercial clients seeking productive solutions for development technologies. As of December 31, 2012, the Company is engaged in a range of activities, in which it seek to commercialize technologies and products in the industry sectors, which include in process quality assurance for manufacturing; aerospace and defense manufacturing; additive manufacturing; active protection systems for defending light armored vehicles; advanced materials for munitions; advanced materials for sporting goods; advanced manufacturing technologies, and dental implant and biomedical prosthetics technologies.
Sumner & Lawrence Limited (Sumner), based in Santa Fe, New Mexico, provides consulting services to the public sector, especially with regard to emerging technologies and alternative applications of established technologies. Sumner holds ongoing contracts with government agencies and the appropriate levels of security clearance for those contracts. Sumner's clients include the State Department, the Department of Defense, the Department of Energy, various military services and affiliated agencies, the National Laboratories, and contractors to these organizations.
Advisors' Opinion:- [By James E. Brumley]
For veteran traders who've kept tabs on Sigma Labs Inc. (OTCMKTS:SGLB) over the past three months or so, it may be surprising to hear someone suggest it as a buy. Like so many other stocks of its ilk have done since the beginning of the organized market, SGLB went from (proverbially) zero to hero between late May and mid-July with a move from $0.025 to a peak of $0.118 only to fall back to the $0.04 level a couple of weeks later. It's the relatively common "one hit wonder", and if Sigma Labs followed the usual pattern of other small stocks that burned brilliantly for a few days, we wouldn't see anything particularly bullish from SGLB for a few months, if not years.
No comments:
Post a Comment